SCHEMBL25909688

SCHEMBL25909688

Nc1nc2ccc(-c3ccccc3C(F)F)nc2s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.34
PI4KA P42356 2/20 0.34
PI4KB Q9UBF8 2/20 0.34
PIK3CD O00329 1/20 0.33
PIK3CG P48736 1/20 0.33
AXL P30530 1/20 0.33
GFER P55789 1/20 0.33
TRPA1 O75762 1/20 0.33
MPL P40238 1/20 0.33
ABL1 P00519 1/20 0.32
CYP3A4 P08684 1/20 0.32
RAB9A P51151 4/20 0.32
NPC1 O15118 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
MAPT P10636 3/20 0.32
TP53 P04637 1/20 0.32
HTT P42858 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25909691 0.82 GFER (0.47) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
SCHEMBL24071164 0.78 PTPN1 (0.42) PIK3CAPI4KAPI4KBABL1CYP3A4
SCHEMBL24071100 0.77 MPL (0.45) MPLRAB9ANPC1MEN1ALDH1A1
SCHEMBL25909689 0.74 ABL1 (0.55) ABL1CYP3A4RAB9ANPC1SMN1; SMN2
SCHEMBL2270416 0.72 MAPK14 (0.40) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
SCHEMBL16460428 0.71 PIK3CD (0.42) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
SCHEMBL30526832 0.68 ALDH1A1 (0.50) PIK3CAPI4KAPI4KBAXLGFER
SCHEMBL30526627 0.67 CLK1 (0.52) PIK3CAPIK3CGABL1CYP3A4RAB9A
SCHEMBL8143280 0.66 PIK3CD (0.53) PIK3CAPI4KAPI4KBPIK3CDPIK3CG
SCHEMBL30858903 0.66 AXL (0.48) PIK3CAPI4KAPI4KBPIK3CDPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234967-A1 Fused Azole Heterocycles as AHR Antagonists SAIL BIOMEDICINES, INC. 2023-07-27 US disclosed
US-20230234967-A1 Fused Azole Heterocycles as AHR Antagonists SAIL BIOMEDICINES, INC. 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234967-A1 Fused Azole Heterocycles as AHR Antagonists AHR, ARNT, AIPL1 PIK3CA 1734/4885PI4KA 1426/4885PI4KB 1126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.